Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Mifepristone on Uterine Fibroids and Breast Tissue

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Uterine fibroids requiring treatment~* Good general health~* Willing and able to participate after giving informed consent~Exclusion Criteria:~* Need for immediate surgery~* Concomitant hormonal treatment (HRT)~* History of malignant disorder of the breast~* Any contraindication for mifepristone~Criteria for retrospective exclusion:~Subjects may be excluded from analysis if one of the following applies:~* Any violation of the study protocol~* Lack of essential data

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): None
- I (Type: ACTIVE_COMPARATOR): Mifepristone (Mifegyne) 50 mg every other day for 3 months

Based on this trial design, predict the completion outcome and termination type (if applicable).